429 related articles for article (PubMed ID: 8225491)
1. Combined micropreparative techniques with synchronous fluorescence spectroscopy or 32P-postlabelling assay for carcinogen-DNA adduct determination.
Shields PG; Kato S; Bowman ED; Petruzzelli S; Cooper DP; Povey AC; Weston A
IARC Sci Publ; 1993; (124):243-54. PubMed ID: 8225491
[TBL] [Abstract][Full Text] [Related]
2. Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes.
Shields PG; Bowman ED; Harrington AM; Doan VT; Weston A
Cancer Res; 1993 Aug; 53(15):3486-92. PubMed ID: 8339251
[TBL] [Abstract][Full Text] [Related]
3. Analysis of polycyclic aromatic hydrocarbon-DNA adducts by postlabelling with the weak beta-emitters 35S-phosphorothioate and 33P-phosphate, immobilized boronate chromatography and high-performance liquid chromatography.
Baird WM; Lau HH; Schmerold I; Coffing SL; Brozich SL; Lee H; Harvey RG
IARC Sci Publ; 1993; (124):217-26. PubMed ID: 8225488
[TBL] [Abstract][Full Text] [Related]
4. 32P-postlabelling methods for cyclic DNA adducts.
Watson WP; Crane AE; Steiner S
IARC Sci Publ; 1993; (124):255-62. PubMed ID: 8225493
[TBL] [Abstract][Full Text] [Related]
5. Benzo[a]pyrene-7,8-quinone-3'-mononucleotide adduct standards for 32P postlabeling analyses: detection of benzo[a]pyrene-7,8-quinone-calf thymus DNA adducts.
Balu N; Padgett WT; Nelson GB; Lambert GR; Ross JA; Nesnow S
Anal Biochem; 2006 Aug; 355(2):213-23. PubMed ID: 16797471
[TBL] [Abstract][Full Text] [Related]
6. Analysis of DNA adducts in smokers' lung and urothelium by 32P-postlabelling: metabolic phenotype dependence and comparisons with other exposure markers.
Bartsch H; Castegnaro M; Camus AM; Schouft A; Geneste O; Rojas M; Alexandrov K
IARC Sci Publ; 1993; (124):331-40. PubMed ID: 8225503
[TBL] [Abstract][Full Text] [Related]
7. Use of the 32P-postlabelling assay to study transplacental carcinogens and transplacental carcinogenesis.
Randerath K; Liehr JG; Gladek A; Randerath E
IARC Sci Publ; 1989; (96):189-205. PubMed ID: 2509347
[TBL] [Abstract][Full Text] [Related]
8. Improvements in the 32P-postlabelling procedure to quantify bulky aromatic DNA adducts.
Steenwinkel MJ; Roggeband R; van Delft JH; Baan RA
IARC Sci Publ; 1993; (124):65-70. PubMed ID: 7693587
[TBL] [Abstract][Full Text] [Related]
9. A comparison of 32P-postlabelling and immunological methods to examine human lung DNA for benzo[a]pyrene adducts.
Garner RC; Tierney B; Phillips DH
IARC Sci Publ; 1988; (89):196-200. PubMed ID: 3143669
[TBL] [Abstract][Full Text] [Related]
10. High-performance liquid chromatography electrospray ionization tandem mass spectrometry for the detection and quantitation of benzo[a]pyrene-DNA adducts.
Beland FA; Churchwell MI; Von Tungeln LS; Chen S; Fu PP; Culp SJ; Schoket B; Gyorffy E; Minárovits J; Poirier MC; Bowman ED; Weston A; Doerge DR
Chem Res Toxicol; 2005 Aug; 18(8):1306-15. PubMed ID: 16097804
[TBL] [Abstract][Full Text] [Related]
11. 32P-postlabelling and mass spectrometric methods for analysis of bulky, polyaromatic carcinogen-DNA adducts in humans.
Talaska G; Roh JH; Getek T
J Chromatogr; 1992 Sep; 580(1-2):293-323. PubMed ID: 1400827
[TBL] [Abstract][Full Text] [Related]
12. Combined high-performance liquid chromatography/32P-postlabeling assay of N7-methyldeoxyguanosine.
Shields PG; Povey AC; Wilson VL; Weston A; Harris CC
Cancer Res; 1990 Oct; 50(20):6580-4. PubMed ID: 2208119
[TBL] [Abstract][Full Text] [Related]
13. The use of benzo[a]pyrene diolepoxide-modified DNA standards for adduct quantification in 32P-postlabelling to assess exposure to polycyclic aromatic hydrocarbons: application in a biomonitoring study.
Baan RA; Steenwinkel MJ; van Asten S; Roggeband R; van Delft JH
Mutat Res; 1997 Aug; 378(1-2):41-50. PubMed ID: 9288884
[TBL] [Abstract][Full Text] [Related]
14. DNA adducts in tumour, normal peripheral lung and bronchus, and peripheral blood lymphocytes from smoking and non-smoking lung cancer patients: correlations between tissues and detection by 32P-postlabelling and immunoassay.
Gyorffy E; Anna L; Gyori Z; Segesdi J; Minárovits J; Soltész I; Kostic S; Csekeo A; Poirier MC; Schoket B
Carcinogenesis; 2004 Jul; 25(7):1201-9. PubMed ID: 15001535
[TBL] [Abstract][Full Text] [Related]
15. Dosimeters of human exposure to carcinogens: polycyclic aromatic hydrocarbon-macromolecular adducts.
Weston A; Willey JC; Manchester DK; Wilson VL; Brooks BR; Choi JS; Poirier MC; Trivers GE; Newman MJ; Mann DL
IARC Sci Publ; 1988; (89):181-9. PubMed ID: 3143667
[TBL] [Abstract][Full Text] [Related]
16. Recovery of bulky DNA adducts by the regular and a modified 32P-postlabelling assay; influence of the DNA-isolation method.
Kovács K; Anna L; Rudnai P; Schoket B
Mutat Res; 2011 Mar; 721(1):95-100. PubMed ID: 21237286
[TBL] [Abstract][Full Text] [Related]
17. Results of an interlaboratory trial of 32P-postlabelling.
Phillips DH; Castegnaro M
IARC Sci Publ; 1993; (124):35-49. PubMed ID: 8225506
[TBL] [Abstract][Full Text] [Related]
18. Detection of polycyclic aromatic hydrocarbon-DNA adducts in human lung.
Weston A; Bowman ED; Shields PG; Trivers GE; Poirier MC; Santella RM; Manchester DK
Environ Health Perspect; 1993 Mar; 99():257-9. PubMed ID: 8319638
[TBL] [Abstract][Full Text] [Related]
19. 32P-postlabelling in studies of polycyclic aromatic hydrocarbon activation.
Ross JA; Nesnow S
IARC Sci Publ; 1993; (124):71-8. PubMed ID: 8225511
[TBL] [Abstract][Full Text] [Related]
20. Aromatic DNA adducts in white blood cells of foundry workers.
Hemminki K; Perera FP; Phillips DH; Randerath K; Reddy MV; Santella RM
IARC Sci Publ; 1988; (89):190-5. PubMed ID: 3143668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
